Drug Information

Drug General Information
Drug ID
D0Q1GL
Former ID
DIB002766
Drug Name
CT-200
Indication Cancer [ICD9: 140-229; ICD10:C00-C96] Phase 1 [548651]
Company
Celleron Therapeutics
Target and Pathway
Target(s) Histone deacetylase Target Info Inhibitor [549783]
References
Ref 548651Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800027375)
Ref 549783Clinical pipeline report, company report or official report of Celleron.

If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.